Christopher I Wright - Net Worth and Insider Trading
Christopher I Wright Net Worth
The estimated net worth of Christopher I Wright is at least $1 Million dollars as of 2026-08-13. Christopher I Wright is the Director of Alkermes PLC and owns about 25,680 shares of Alkermes PLC (ALKS) stock worth over $1 Million. Christopher I Wright is also the Chief Medical Officer of Cyclerion Therapeutics Inc and owns about 2,136 shares of Cyclerion Therapeutics Inc (CYCN) stock worth over $8,309. Details can be seen in Christopher I Wright's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher I Wright has not made any transactions after 2026-06-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher I Wright
Christopher I Wright Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher I Wright owns 3 companies in total, including Cyclerion Therapeutics Inc (CYCN) , Alkermes PLC (ALKS) , and Wave Life Sciences Inc (WVE) .
Click here to see the complete history of Christopher I Wright’s form 4 insider trades.
Insider Ownership Summary of Christopher I Wright
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| CYCN | Cyclerion Therapeutics Inc | 2021-02-25 | Chief Medical Officer |
| ALKS | Alkermes PLC | 2026-06-12 | director |
| WVE | Wave Life Sciences Inc | 2026-04-09 | Chief Medical Officer |
Christopher I Wright Latest Holdings Summary
Christopher I Wright currently owns a total of 2 stocks. Among these stocks, Christopher I Wright owns 25,680 shares of Alkermes PLC (ALKS) as of June 12, 2026, with a value of $1 Million and a weighting of 99.36%. Christopher I Wright also owns 2,136 shares of Cyclerion Therapeutics Inc (CYCN) as of February 25, 2021, with a value of $8,309 and a weighting of 0.64%.
Latest Holdings of Christopher I Wright
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALKS | Alkermes PLC | 2026-06-12 | 25,680 | 50.28 | 1,291,190 |
| CYCN | Cyclerion Therapeutics Inc | 2021-02-25 | 2,136 | 3.89 | 8,309 |
Holding Weightings of Christopher I Wright
Christopher I Wright Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher I Wright has made a total of 1 transactions in Alkermes PLC (ALKS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Alkermes PLC is the sale of 2,000 shares on June 12, 2026, which brought Christopher I Wright around $90,200.
According to the SEC Form 4 filings, Christopher I Wright has made a total of 0 transactions in Cyclerion Therapeutics Inc (CYCN) over the past 5 years. The most-recent trade in Cyclerion Therapeutics Inc is the sale of 132 shares on February 25, 2021, which brought Christopher I Wright around $10,522.
Insider Trading History of Christopher I Wright
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Christopher I Wright Trading Performance
Christopher I Wright Ownership Network
Ownership Network List of Christopher I Wright
Ownership Network Relation of Christopher I Wright
Christopher I Wright Owned Company Details
What does Cyclerion Therapeutics Inc do?
Who are the key executives at Cyclerion Therapeutics Inc?
Christopher I Wright is the Chief Medical Officer of Cyclerion Therapeutics Inc. Other key executives at Cyclerion Therapeutics Inc include 10 percent owner Slate Path Capital Lp , Chief Financial Officer Rhonda M. Chicko , and President Regina Margaret Graul .
Cyclerion Therapeutics Inc (CYCN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Cyclerion Therapeutics Inc (CYCN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclerion Therapeutics Inc (CYCN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Cyclerion Therapeutics Inc (CYCN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cyclerion Therapeutics Inc Insider Transactions
Christopher I Wright Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher I Wright. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Christopher I Wright's mailing address is: Dublin 4 L2 D04 C5y6.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
